Figure 1.

Summary of status of breast cancer immunotherapy investigational trials, by phase. (Anti-tumor antibodies such as trastuzumab are not listed.)

Summary of status of breast cancer immunotherapy investigational trials, by phase. (Anti-tumor antibodies such as trastuzumab are not listed.)